UBC Medical Indonesia Tbk. vs Surya Semesta Internusa Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Surya Semesta Internusa Tbk. trades at Rp1,780 (market cap 7.25T, 89.17M 24h volume). The key difference: Surya Semesta Internusa Tbk. is far larger — about 12.6× UBC Medical Indonesia Tbk.'s market cap, and Surya Semesta Internusa Tbk. is more actively traded (89.17M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SSIA | |
|---|---|---|
Market Cap | 576.7B | 7.25T |
Volume | 3.48M | 89.17M |
Lot | 34.82K | 891.65K |
Turnover | 522.79M | 154.58B |
Average Price | 150.13 | 1,733.63 |
Value | 522.79M | 154.58B |
Indicative Equilibrium Price | 148 | 1,780 |
Indicative Equilibrium Volume | 350 | 19.08K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.
Read more on SSIA →